AstraZeneca News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.09.23	AstraZeneca: FDA Issues CRL Regarding SBLA Of Ultomiris In NMOSD (RTTNews)
04.09.23	AstraZeneca's Calquence Approved In China For Chronic Lymphocytic Leukaemia (RTTNews)
31.08.23	AZN : Enhertu Granted Breakthrough Therapy Designations In US For Multiple HER2 Expressing Cancers (RTTNews)
25.08.23	AstraZeneca Files Legal Challenge To Protect Access To Medicines For Cancer And Rare Diseases (RTTNews)
24.08.23	AstraZeneca Announces Approval Of Soliris In Japan For Expanded Use (RTTNews)
28.07.23	AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up (RTTNews)
27.07.23	AstraZeneca: Phase II Trial Of Enhertu In Advanced Solid Tumors Shows Clinically Meaningful PFS & OS (RTTNews)
18.07.23	FDA Approves AstraZeneca And Sanofi's Beyfortus To Protect Infants Against RSV Disease (RTTNews)
03.07.23	AstraZeneca Says Dato-DXd Meets Dual Primary Endpoint Of PFS In Phase III Trial In Lung Cancer (RTTNews)
29.06.23	AstraZeneca: Long-term Survival Data Supports Use Of STRIDE Regimen To Treat Unresectable HCC (RTTNews)
19.06.23	AstraZeneca Plans To Spin Off China Business Amid Tensions: FT (RTTNews)
13.06.23	AstraZeneca Partners Vanguard Renewables To Use Renewable Natural Gas In The U.S. By End Of 2026 (RTTNews)
09.06.23	AstraZeneca: FDA Committee Recommends Nirsevimab For RSV Lower Respiratory Tract Disease In Infants (RTTNews)
09.06.23	Syncona: Quell Signs Cell Therapy Deal With AstraZeneca Focused On Autoimmune Diseases (RTTNews)
05.06.23	AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial (RTTNews)
03.06.23	AstraZeneca Announces Positive Results From Interim Analysis Of DUO-O Phase III Trial (RTTNews)
01.06.23	AstraZeneca Announces Discontinuation Of IBD Development Programme For Brazikumab (RTTNews)
01.06.23	AstraZeneca's Lynparza Gets FDA Approval For BRCAm Prostate Cancer (RTTNews)
30.05.23	BioLight Inks Agreement With Alexion To Explore Technology For Diagnosis Of Retinal Diseases (RTTNews)
27.05.23	Biotech Stocks Facing FDA Decision In June 2023 (RTTNews)
26.05.23	AstraZeneca Reports Positive Results From DUO-E Phase III Trial - Quick Facts (RTTNews)
18.05.23	FibroGen Announces Positive Data From Phase 3 Study Of Roxadustat For Treatment Of Anemia (RTTNews)
17.05.23	AstraZeneca Reports Positive Trial Results Of Tagrisso Plus Chemotherapy In FLAURA2 Phase III Trial (RTTNews)
09.05.23	FDA Approves AstraZeneca's Farxiga In The US For Heart Failure (RTTNews)
27.04.23	AstraZeneca Q1 Core Profit Rises, Revenue Ex COVID-19 Up 15% At CER; Reiterates FY23 Guidance (RTTNews)
17.04.23	Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting (PR Newswire)
17.04.23	AZN : IMFINZI-based Treatment Reduces Risk Of Disease Recurrence In Lung Cancer In Phase III Trial (RTTNews)
14.04.23	New analysis of Phase II data at AACR assesses ImaginAb's investigational CD8 ImmunoPET technology's ability to predict response in immunotherapy (PR Newswire)
10.04.23	Sobi To Streamline Nirsevimab Agreement (RTTNews)
05.04.23	AstraZeneca : Lynparza Combination Improves PFS In Phase III Ovarian Cancer Trial (RTTNews)
03.04.23	AstraZeneca: CHMP Recommendes Ultomiris For EU Approval For Neuromyelitis Optica Spectrum Disorde (RTTNews)
31.03.23	Biotech Stocks Facing FDA Decision In April 2023 (RTTNews)
27.03.23	Ionis Pharma Reports Positive 66-week Results Of Eplontersen Phase 3 Study In ATTRv-PN (RTTNews)
06.03.23	AstraZeneca: Enhertu DESTINY-PanTumor02 Shows Positive Results (RTTNews)
07.02.23	AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure (RTTNews)
02.02.23	AstraZeneca, Amgen's Tezspire Pre-filled Pen Receives FDA Approval In US For Asthma (RTTNews)
23.01.23	AstraZeneca Commencs Tender Offer To Buy CinCor Pharma (RTTNews)
17.01.23	AIM ImmunoTech Inks Pancreatic Cancer Clinical Research Deals With AstraZeneca, Erasmus (RTTNews)
09.01.23	AstraZeneca To Buy CinCor Pharma In Up To $1.8 Bln Deal - Quick Facts (RTTNews)
28.12.22	AstraZeneca: Imfinzi + Imjudo Approved In Japan For Advanced Liver, Biliary Tract And Lung Cancers (RTTNews)
21.12.22	CytoSorbents : DSMB Recommends To Continue Pivotal STAR-T Trial Without Any Modifications (RTTNews)
21.12.22	AstraZeneca: Lynparza In Combination With Abiraterone Approved In EU For Prostate Cancer (RTTNews)
21.12.22	AstraZeneca : Imfinzi Combination Approved In EU For Advanced Biliary Tract Cancer Treatment (RTTNews)
19.12.22	AstraZeneca: Enhertu Gets CHMP Recommendation For EU Approval For HER2-low Metastatic Breast Cancer (RTTNews)
19.12.22	AstraZeneca: CHMP Recommends Imfinzi And Imjudo Combinations For Advanced Liver And Lung Cancers (RTTNews)
19.12.22	AstraZeneca: Imfinzi Fails To Meet Statistical Significance For Primary Goals In PEARL Trial (RTTNews)
19.12.22	AstraZeneca: CHMP Recommends Forxiga For Approval In Adults For Treatment Of Symptomatic Chronic HF (RTTNews)
15.12.22	AstraZeneca: FDA To Extend PDUFA Date Regarding SNDA For Lynparza With Abiraterone (RTTNews)
09.12.22	AstraZeneca: Datopotamab Deruxtecan Shows Encouraging Objective Response Rate In Phase I Trial (RTTNews)
08.12.22	AZN:Camizestrant Delayed Disease Progression In Advanced ER-Positive Breast Cancer In Phase II Trial (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Roche Hldg G	247.00	0.12 %	K V
Sonova Hldg	292.20	-0.20 %	K V
Swisscom	498.00	-0.70 %	K V
Givaudan	3’879.00	-0.72 %	K V
Kuehne+Nagel Int	200.80	-0.74 %	K V
Lonza Grp	518.80	-1.78 %	K V
Holcim	85.40	-1.82 %	K V
Part Grp Hldg	1’191.50	-2.10 %	K V
UBS Group	26.28	-2.27 %	K V
Sika	213.60	-2.29 %	K V

mehr

18.12.24		Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer
04.12.24		Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich
03.12.24		Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende
03.12.24		Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus
03.12.24		Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück
03.12.24		NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer
12.11.24		AstraZeneca-Aktie im Minus: AstraZeneca meldet starkes 3. Quartal und passt Prognose nach oben an
07.11.24		AstraZeneca-Aktie rutscht ab: Festnahme des China-Chefs von AstraZeneca

18.12.24

Schwacher Handel in New York: NASDAQ 100 am Mittwochnachmittag schwächer

04.12.24

Zuversicht in New York: NASDAQ 100 zum Handelsstart freundlich

03.12.24

Starker Wochentag in New York: NASDAQ 100 steigt zum Handelsende

03.12.24

Starker Wochentag in New York: NASDAQ 100 am Nachmittag mit Kursplus

03.12.24

Schwacher Wochentag in New York: NASDAQ 100 fällt am Mittag zurück

03.12.24

NASDAQ-Handel NASDAQ 100 zum Handelsstart schwächer